glp 1 drugs tirzepatide Use of the dual GIP/GLP-1 drug (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 among patients with type 2 diabetes, a large retrospective cohort Tirzepatide Associated with Lower POAG,
Description
About 19% of large employers now cover GLP-1 drugs used primarily for weight
Retatrutide works across all three, which is why it is often described as a multi-pathway metabolic therapy
It's the latest diabetes drug approved for weight loss.
Ozempic lowers fasting and postprandial blood glucose by stimulating insulin secretion in a glucose-dependent manner
